TSTianhan Sun

Tianhan Sun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tianhan Sun has a total of 46 co-authors. Here are the top co-authors by number of shared publications:

  • Hongyuan Cui

    Department of General Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China

    3 shared publications
  • Fei Xiao

    Clinical Biobank, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Gaoyuan Sun

    Clinical Biobank, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China

    2 shared publications
  • Boyue Jiang

    Department of General Surgery, Department of Hepato‐Bilio‐Pancreatic Surgery Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing People's Republic of China

    1 shared publication
  • Boyue Jiang

    Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China

    1 shared publication
  • Fangqing Zhao

    Beijing Institutes of Life Science, Chinese Academy of Sciences, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer

    by Xuanmei Luo, Jian Cui, Jinxin Shi, Gaoyuan Sun, Lili Zhang, Yayu Li, Yingyu Guo, Lu Kuai, Tianhan Sun, Qi Luo, et al.

    Background: Delayed detection of recurrence significantly contributes to colorectal cancer (CRC) mortality, underscoring the need for robust prognostic biomarkers. Although extrachromosomal circular DNA (eccDNA) is a known oncogenic driver, its prognostic utility in CRC remains largely unexplored. Methods: In this 6-year prospective cohort study, full-length eccDNA profiling of 153 plasma samples was performed using Nanopore sequencing. Differential eccDNA signatures between recurrence (R, n = 20) and non-recurrence (NR, n = 133) patients enabled construction of predictive models for recurrence and mortality. Functional validation of eccDNAs was conducted in HCT116 cells. Results: Compared to NR patients, R patients exhibited enrichment of eccDNAs derived from chromosome 9, shorter median eccDNA lengths, and reduced variability in eccDNA length. All 4.9–5.0 kb eccDNAs derived from CKM , while other eccDNAs showed a strong genomic distribution correlation between groups (Spearman’s ρ = 0.73). Promoter-derived eccDNAs were enriched in R patients, particularly from the promoter of CARD9 (eccPromoter-CARD9, 10.4-fold increase). Overexpression of eccPromoter-CARD9 significantly promoted CRC cell proliferation and migration. R patients exhibited elevated eccDNAs harboring the hsa-mir-374c cluster in plasma and tissues, and their corresponding miRNAs demonstrated exceptional diagnostic accuracy in CRC-related TCGA cohorts. An eccDNA-based random forest classifier achieved superior recurrence prediction accuracy (AUC > 0.8), correlating with shorter time-to-recurrence (HR = 3.79) and elevated CA125 and CEA levels. Additional eccDNA-based models effectively predicted recurrence-associated mortality (AUC ≥ 0.93). Conclusions: The plasma eccDNA landscape may serve as an early and powerful non-invasive biomarker for CRC prognostication, optimizing risk stratification and guiding personalized treatment.


  • Open Access

    The 5‐Methylcytosine RNA Modification in Hepatitis B Virus‐Negative Hepatocellular Carcinoma: Insights From Long‐Read Nanopore Sequencing

    by Tianhan Sun, Liying Zhou, XiaoQing Li, Ryan Xiao, Gaoyuan Sun, Lili Zhang, Yifei Li, Wei Huang, Yayu Li, Lu Kuai, et al.

    5‐Methylcytosine (m5C) RNA modification contributes to tumor initiation and progression. However, its transcriptome‐wide distribution patterns and biological implications in hepatitis B virus (HBV)‐negative hepatocellular carcinoma (HCC) remain poorly understood. Therefore, this study employs long‐read Nanopore direct RNA sequencing to systematically elucidate the mechanisms of m5C‐mediated epigenetic reprogramming in HBV‐negative HCC. Paired tumor and adjacent normal tissues from three HBV‐negative HCC patients were collected for Nanopore sequencing. Transcriptome‐wide m5C sites were profiled using the CHEUI tool, followed by a comprehensive comparison between tumor and adjacent normal tissue groups regarding the number of m5C sites, their genomic distribution characteristics, and the expression levels of m5C regulators. Finally, an integrated analysis of transcriptomic and methylation data was conducted to identify m5C‐related prognostic indicators in HCC. Tumor tissues exhibited a global increase in m5C sites abundance, with differential modifications enriched on chromosomes 1–3. Genes harboring m5C modifications were significantly enriched in immune and inflammatory pathways, suggesting a potential role for this epitranscriptomic mark in remodeling the tumor immune microenvironment. Consistent upregulation of m5C regulators, including NSUN family members and ALYREF , at both gene and isoform levels, correlated with increased methylation activity. Elevated m5C coupled with decreased CES3 expression were associated with poorer overall survival. Additionally, TMEM234 showed prognostic significance despite unchanged bulk expression in public datasets. m5C modifications are globally altered in HBV‐negative HCC and may contribute to post‐transcriptional regulation and aberrant expression. These findings highlight the potential of m5C as both a prognostic biomarker and a therapeutic target in HBV‐negative HCC.


  • Open Access

    Surgical Intervention and Prognosis of Intraductal Papillary Mucinous Adenoma in Elderly Patients: A Single Center Retrospective Study

    by Tianhan Sun, Meilan Liu, Qing Wang, Boyue Jiang, Tong Li, Jianfu Cao, Jinghai Song, Jingyong Xu, Hongyuan Cui

    Objective: The incidence of intraductal papillary mucinous neoplasm (IPMN) is rising among elderly patients. This study aims to investigate the clinical features of IPMN in elderly patients (≥ 60 years), analyze risk factors for high‐grade dysplasia (HGD) and invasive cancer (IC), and provide treatment recommendations for elderly patients with IPMN.Methods: In this single‐center retrospective case–control study, 58 consecutive elderly patients (≥ 60 years) who underwent IPMN surgery at Beijing Hospital between January 2014 and November 2023 were included. Clinical characteristics across IPMN subtypes were compared, risk factors were analyzed, and the predictive values of the 2017 Fukuoka and 2023 Kyoto guidelines were evaluated. Follow‐up and survival outcomes were also examined.Results: The proportion of patients with main‐duct IPMN (MD‐IPMN) and mixed‐type IPMN (MT‐IPMN) who had diabetes was significantly higher than among those with branch‐duct IPMN (BD‐IPMN) (p < 0.05). The average postoperative hospital stay for patients with low‐grade dysplasia (LGD) was 17.7 days (range, 6–53 days), while for patients with HGD/IC, it was 25.5 days (range, 9–90 days), with a statistically significant difference (p < 0.05). Jaundice, elevated CA19‐9, elevated CEA, main duct (MD) > 10 mm, and IPMN subtype were significant predictors of HGD/IC (p < 0.05), with elevated CA19‐9 and IPMN subtype identified as independent risk factors (p < 0.05). The 2023 Kyoto guidelines showed higher sensitivity but lower specificity than the 2017 Fukuoka guidelines for detecting HGD/IC (p < 0.05 for both). There was a statistically significant difference in overall survival between patients with LGD and those with HGD/IC following surgery (p < 0.05), while no significant difference in postoperative survival was observed between HGD/IC patients with and without lymph node metastasis (p > 0.05).Conclusions: Surgical resection is recommended for elderly patients with MD‐IPMN or MT‐IPMN combined with elevated CA19‐9. The 2017 Fukuoka guidelines are preferable to the 2023 Kyoto guidelines for managing elderly IPMN patients.


  • Open Access

    Gut microbiome and metabolome characteristics of patients with cholesterol gallstones suggest the preventive potential of prebiotics

    by Ye Liu, Hexin Li, Tianhan Sun, Gaoyuan Sun, Boyue Jiang, Meilan Liu, Qing Wang, Tong Li, Jianfu Cao, Li Zhao, et al.

    Cholesterol gallstones (CGS) still lack effective noninvasive treatment. The etiology of experimentally proven cholesterol stones remains underexplored. This cross‐sectional study aims to comprehensively evaluate potential biomarkers in patients with gallstones and assess the effects of microbiome‐targeted interventions in mice. Microbiome taxonomic profiling was conducted on 191 samples via V3−V4 16S rRNA sequencing. Next, 60 samples (30 age‐ and sex‐matched CGS patients and 30 controls) were selected for metagenomic sequencing and fecal metabolite profiling via liquid chromatography‐mass spectrometry. Microbiome and metabolite characterizations were performed to identify potential biomarkers for CGS. Eight‐week‐old male C57BL/6J mice were given a lithogenic diet for 8 weeks to promote gallstone development. The causal relationship was examined through monocolonization in antibiotics‐treated mice. The effects of short‐chain fatty acids such as sodium butyrate, sodium acetate (NaA), sodium propionate, and fructooligosaccharides (FOS) on lithogenic diet‐induced gallstones were investigated in mice. Gut microbiota and metabolites exhibited distinct characteristics, and selected biomarkers demonstrated good diagnostic performance in distinguishing CGS patients from healthy controls. Multi‐omics data indicated associations between CGS and pathways involving butanoate and propanoate metabolism, fatty acid biosynthesis and degradation pathways, taurine and hypotaurine metabolism, and glyoxylate and dicarboxylate metabolism. The incidence of gallstones was significantly higher in the Clostridium glycyrrhizinilyticum group compared to the control group in mice. The grade of experimental gallstones in control mice was significantly higher than in mice treated with NaA and FOS. FOS could completely inhibit the formation of gallstones in mice. This study characterized gut microbiome and metabolome alterations in CGS. C. glycyrrhizinilyticum contributed to gallstone formation in mice. Supplementing with FOS could serve as a potential approach for managing CGS by altering the composition and functionality of gut microbiota.


  • Open Access

    Forced expiratory volumes in 3 s is a sensitive clinical measure for assessment of bronchodilator reversibility in elderly Chinese with severe lung function impairment

    by Mingming Pan, Hongsheng Zhang, Tieying Sun

    Purpose: Sensitively assessing bronchial reversibility by spirometry is difficult in patients with serious airflow limitation and the elderly. Some patients cannot exhale for ≥6 s to achieve FVC testing criteria. The aim of this study was to assess if FEV3 could be a more sensitive and an acceptable surrogate for evaluating bronchial reversibility in such patients. Patients and methods: Subjects who had undergone pulmonary function examination in Beijing hospital from July 2003 to April 2015 were included in the study. Patients with FEV11, FEV3 and FVC in response to a bronchodilator was estimated. Results: A total of 7745 tests on elderly subjects with a median age of 71 years were reviewed. The severely lung function–impaired group of 1728 accounted for 22.3% of the total number of subjects. There were significantly more patients in the severely lung function–impaired group who exhibited positive response in FEV3 or FVC and negative response in FEV1 after bronchodilator test (FEV1 negative response but FVC positive response, χ2=626.97, P1 negative response but FEV3 positive response, χ2=372.83, P1 increased and then declined, while ΔFVC and ΔFEV3 increased progressively. Changes in FEV3 or FVC significantly exceeded the change in FEV1 in the severely lung function–impaired groups (PConclusion: In elderly subjects, especially those with severe lung function impairment, FEV3 combined with FVC is a more effective and sensitive primary clinical outcome measure to detect bronchial reversibility. In subjects who cannot complete ≥6 s forced expiration and whose FVC is unreliable, FEV3 combined with FEV1 might be clinically more valuable in detecting bronchial reversibility.

  • Open Access

    [The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells].

    by Shuhong Ming, Jing Gao, Tieying Sun

    The Relationship between the TSLC1 Silencing and DNA Methylation in Human Lung Cancer Cells